Prognostic study of cardiac and renal events in japanese patients with chronic kidney disease and cardiovascular risk using myocardial perfusion SPECT: J-ACCESS 3 study design

Therapeutic Apheresis and Dialysis

Volumn 14, Issue 4, 2010, Pages 379-385

  Nakamura, Satoko ^a   Kawano, Yuhei ^a   Hase, Hiroki ^b   Hatta, Tsuguru ^c   Nishimura, Shigeyuki ^d   Moroi, Masao ^b   Nakagawa, Susumu ^e   Kasai, Tokuo ^f   Kusuoka, Hideo ^g   Takeishi, Yasuchika ^h   Nakajima, Kenichi ⁱ   Momose, Mitsuru ^j   Takehana, Kazuya ^k   Nanasato, Mamoru ^l   Yoda, Syunichi ^m   Nishina, Hidetaka ⁿ   Matsumoto, Naoya ^m   Nishimura, Tsunehiko ^o  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

^c Ohmihachiman Community Medical Center   (Japan)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

^e SAISEIKAI CENTRAL HOSPITAL   (Japan)

^f JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g OSAKA NATIONAL HOSPITAL   (Japan)

^h FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

ⁱ KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^j TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^k KANSAI MEDICAL UNIVERSITY   (Japan)

^l NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^m NIHON UNIVERSITY   (Japan)

ⁿ TSUKUBA MEDICAL CENTER HOSPITAL   (Japan)

^o KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

more..

Author keywords

Chronic kidney disease; Glomerular filtration rate; Myocardial perfusion imaging; Public health; Single photon emission computed tomography

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART MUSCLE PERFUSION; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; CARDIOVASCULAR DISEASES; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COHORT ANALYSIS; COMPLICATION; FEMALE; JAPAN; MALE; METHODOLOGY; MORTALITY; MULTICENTER STUDY; MYOCARDIAL PERFUSION IMAGING; PROCEDURES; PROSPECTIVE STUDY; RISK FACTOR;

CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; JAPAN; KIDNEY FAILURE, CHRONIC; MALE; MYOCARDIAL PERFUSION IMAGING; PROGNOSIS; PROSPECTIVE STUDIES; RESEARCH DESIGN; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77955061729     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2010.00823.x     Document Type: Article

References (23)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risk of death, cardio vascular events, and hospitalization. N Engl J Med 2004 351 : 1296 1305.
2. Weiner DE, Tighiouart H, Amin MG et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004 15 : 1307 1315.
3. Keith DS, Nichols GA, Guillon CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004 164 : 659 663.
4. Anaveker NS, McMurray JJV, Velazquez EJ et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004 351 : 1285 1295.
5. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002 39 (Suppl 1 S1 S266.
6. Levey AS, Eckardt KU, Tsukamoto Y et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005 67 : 2089 2100.
7. Levey AS, Bosch JP, Lewis JB, Green T, Eknoyan G, Levy A. A more accurate methods to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999 130 : 461 470.
8. Matsuo S, Imai E, Horio M et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from creatinine in Japan. Am J Kidney Dis 2009 53 : 982 986.
9. Imai E, Horio M, Watanabe T et al. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol 2009 13 : 621 630.
10. Dzau VJ, Antman EM, Black HR et al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes. Part II: clinical trial evidence (acute coronary syndromes through renal disease) and future directions. Circulation 2006 114 : 2871 2891.
11. Sarnak MJ, Levey AS, Schoolwerth AC et al. Kidney disease as a risk factor for development of cardiovascular diseases: a statement from the American Heart Association Councils on Kidney in cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 2003 108 : 2154 2169.
12. Hostetter TH. Chronic kidney disease predicts cardiovascular disease. N Engl J Med 2004 351 : 1344 1346.
13. Vanholder R, Massy Z, Argiles A, Spasovski G, Verbeke F. Lamerie N for the European Uremic Toxin Work Group: chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transplant 2005 20 : 1048 1056.
14. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998 32 : S12 S119.
15. Majumdar SR, Kjellstrand CM, Tymchak WJM, Hervas-Malo M, Taylor DA, Teo KK. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial. Am J Kidney Dis 2009 54 : 602 609.
16. Mitsutake R, Miura S, Shiga Y, Kawamura A, Saku K. Is chronic kidney disease associated with coronary artery stenosis or calcification assessed by multi-detector row computed tomography? Intern Med 2008 47 : 1835 1841.
17. Perazella MA. Advanced kidney disease, gadolinium and nephrogenic systemic fibrosis: the perfect storm. Curr Opin Nephrol Hypertens 2009 18 : 519 525.
18. Hatta T, Nishimura S, Nakajima T. Prognostic risk stratification of myocardial ischaemia evaluated by gated myocardial perfusion SPECT in patients with chronic kidney disease. Eur J Nucl Mol Imaging 2009 36 : 1835 1841.
19. Nakajima K, Nishimura T. Inter-institution preference-based variability of ejection fraction and volumes using quantitative gated SPECT with Tc-tetrofosmin: a multicentre study involving 106 hospitals. Eur J Nucl Med Mol Imaging 2006 33 : 127 133.
20. Kusuoka H, Nishimura S, Yamashina A, Nakajima K, Nishimura T, for the J-ACCESS investigators. Surveillance study for creating the national clinical database related to ECG-gated myocardial SPECT of ischemic heart disease: J-ACCESS study design. Ann Nucl Med 2006 20 : 195 202.
21. Momose M, Babazono T, Kondo C, Kobayashi H, Nakajima T, Kusakabe K. Prognostic significance of stress myocardial ECG-gated perfusion imaging in asymptomatic patients with diabetic chronic kidney disease on initiation of haemodialysis. Eur J Nucl Mol Imaging 2009 36 : 1315 1321.
22. Hakeem A, Bhatti S, Dille KS et al. Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death. Circulation 2008 118 : 2540 2549.
23. Hachamovitch R, Berman DS, Shaw LJ et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death-differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998 97 : 535 543.